ECOMB (ECOMB) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
29 Aug, 2025Executive summary
Net loss after financial items for the group was -2,646 TSEK compared to -1,275 TSEK year-over-year, with net sales dropping to 662 TSEK from 5,648 TSEK.
Cash position remains very strained, with only 17 TSEK in liquid assets at period end, down from 355 TSEK last year.
Despite current financial challenges, management expresses strong optimism for future prospects, citing a robust pipeline and expected contracts.
Financial highlights
Group net sales for H1 2025 were 662 TSEK, a sharp decline from 5,648 TSEK in H1 2024.
Group net loss after financial items widened to -2,646 TSEK from -1,275 TSEK year-over-year.
Parent company net loss after financial items was -2,429 TSEK versus -1,124 TSEK last year.
Cash and cash equivalents at period end were 17 TSEK for the group and 0 TSEK for the parent company.
Order backlog decreased during the half-year as projects were completed.
Outlook and guidance
Management anticipates new larger contracts in the near term but notes delays and uncertainties due to the economic climate and risk capital scarcity.
The expected order backlog for 2025-26 is over 30 MSEK, but realization is pending.
Positive long-term outlook based on increased number of high-probability prospects.
Latest events from ECOMB
- Financial turnaround driven by new capital, project wins, and strategic focus on CCS and PFAS.ECOMB
Q4 202527 Feb 2026 - Sales fell, losses narrowed, and a major rights issue will fund new emission and water projects.ECOMB
Q3 202528 Nov 2025 - Revenue surged on project delivery, but losses widened and liquidity remains tight.ECOMB
Q3 202413 Jun 2025 - Sales up, losses incurred, capital raised, and new PFAS tech validated for future growth.ECOMB
Q2 202413 Jun 2025 - Q1 2025 saw steep losses and cash strain, but key projects in NOx and PFAS advanced.ECOMB
Q1 20256 Jun 2025 - Record revenue offset by project losses; PFAS focus and new patents drive future optimism.ECOMB
Q4 20246 Jun 2025